A Stability Program for the Distribution of Drug Products
By Teresa I. Lucas, Rafik H. Bishara, and Robert H. Seevers
Published in: Pharmaceutical Technology JULY 2004
Published on: July 1, 2004
This article outlines distribution stability studies designed to generate additional data to complement pre-formulation development and routine International Conference on Harmonization (ICH) Q1A registration studies. If results from routine studies indicate that the product stability profile is very stable, then one may decide that distribution studies are not warranted. If additional distribution stability studies are needed, they can be developed to test the product’s temperature limitations. In the event that a temperature excursion is higher or lower than the recommended storage condition, these data would be examined to evaluate the effect on product quality.
If you have not yet signed up for the StabilityHub newsletter, join hundreds of other stabilitarians to get the latest news, publications, job opportunities and more!
By submitting this form, you are consenting to receive emails from: StabilityHub, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact